Trial Profile
Study of apatinib in advance osteosarcoma with pulmonary metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions; Therapeutic Use
- 11 Sep 2018 New trial record
- 01 Aug 2018 Results published in the Medicine